Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing

A. Zamò, J. Pischimarov, M. Schlesner, P. Rosenstiel, R. Bomben, H. Horn, T. Grieb, T. Nedeva, C. López, A. Haake, J. Richter, L. Trümper, C. Lawerenz, W. Klapper, P. Möller, M. Hummel, D. Lenze, M. Szczepanowski, L. Flossbach, M. SchrederV. Gattei, G. Ott, R. Siebert, A. Rosenwald, E. Leich

Research output: Contribution to journalArticle

Abstract

Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ∼15-∼50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites. Typical FL mutations also affected t(14;18)-negative FL. Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)-negative FL. Mutated genes showed high BCL2 association in both subgroups. Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)-positive and t(14;18)-negative FL (P<0.01). N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL. These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.

Original languageEnglish
Pages (from-to)685-693
Number of pages9
JournalLeukemia
Volume32
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Exome
Follicular Lymphoma
Glycosylation
Genes
Molecular Sequence Annotation
Immunoglobulins
Nucleotides

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Zamò, A., Pischimarov, J., Schlesner, M., Rosenstiel, P., Bomben, R., Horn, H., ... Leich, E. (2018). Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. Leukemia, 32(3), 685-693. https://doi.org/10.1038/leu.2017.270

Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. / Zamò, A.; Pischimarov, J.; Schlesner, M.; Rosenstiel, P.; Bomben, R.; Horn, H.; Grieb, T.; Nedeva, T.; López, C.; Haake, A.; Richter, J.; Trümper, L.; Lawerenz, C.; Klapper, W.; Möller, P.; Hummel, M.; Lenze, D.; Szczepanowski, M.; Flossbach, L.; Schreder, M.; Gattei, V.; Ott, G.; Siebert, R.; Rosenwald, A.; Leich, E.

In: Leukemia, Vol. 32, No. 3, 01.03.2018, p. 685-693.

Research output: Contribution to journalArticle

Zamò, A, Pischimarov, J, Schlesner, M, Rosenstiel, P, Bomben, R, Horn, H, Grieb, T, Nedeva, T, López, C, Haake, A, Richter, J, Trümper, L, Lawerenz, C, Klapper, W, Möller, P, Hummel, M, Lenze, D, Szczepanowski, M, Flossbach, L, Schreder, M, Gattei, V, Ott, G, Siebert, R, Rosenwald, A & Leich, E 2018, 'Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing', Leukemia, vol. 32, no. 3, pp. 685-693. https://doi.org/10.1038/leu.2017.270
Zamò A, Pischimarov J, Schlesner M, Rosenstiel P, Bomben R, Horn H et al. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. Leukemia. 2018 Mar 1;32(3):685-693. https://doi.org/10.1038/leu.2017.270
Zamò, A. ; Pischimarov, J. ; Schlesner, M. ; Rosenstiel, P. ; Bomben, R. ; Horn, H. ; Grieb, T. ; Nedeva, T. ; López, C. ; Haake, A. ; Richter, J. ; Trümper, L. ; Lawerenz, C. ; Klapper, W. ; Möller, P. ; Hummel, M. ; Lenze, D. ; Szczepanowski, M. ; Flossbach, L. ; Schreder, M. ; Gattei, V. ; Ott, G. ; Siebert, R. ; Rosenwald, A. ; Leich, E. / Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. In: Leukemia. 2018 ; Vol. 32, No. 3. pp. 685-693.
@article{3e1c9aab87304bd280a944b7c55f124c,
title = "Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing",
abstract = "Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ∼15-∼50{\%} of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites. Typical FL mutations also affected t(14;18)-negative FL. Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)-negative FL. Mutated genes showed high BCL2 association in both subgroups. Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)-positive and t(14;18)-negative FL (P<0.01). N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL. These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.",
author = "A. Zam{\`o} and J. Pischimarov and M. Schlesner and P. Rosenstiel and R. Bomben and H. Horn and T. Grieb and T. Nedeva and C. L{\'o}pez and A. Haake and J. Richter and L. Tr{\"u}mper and C. Lawerenz and W. Klapper and P. M{\"o}ller and M. Hummel and D. Lenze and M. Szczepanowski and L. Flossbach and M. Schreder and V. Gattei and G. Ott and R. Siebert and A. Rosenwald and E. Leich",
year = "2018",
month = "3",
day = "1",
doi = "10.1038/leu.2017.270",
language = "English",
volume = "32",
pages = "685--693",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing

AU - Zamò, A.

AU - Pischimarov, J.

AU - Schlesner, M.

AU - Rosenstiel, P.

AU - Bomben, R.

AU - Horn, H.

AU - Grieb, T.

AU - Nedeva, T.

AU - López, C.

AU - Haake, A.

AU - Richter, J.

AU - Trümper, L.

AU - Lawerenz, C.

AU - Klapper, W.

AU - Möller, P.

AU - Hummel, M.

AU - Lenze, D.

AU - Szczepanowski, M.

AU - Flossbach, L.

AU - Schreder, M.

AU - Gattei, V.

AU - Ott, G.

AU - Siebert, R.

AU - Rosenwald, A.

AU - Leich, E.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ∼15-∼50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites. Typical FL mutations also affected t(14;18)-negative FL. Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)-negative FL. Mutated genes showed high BCL2 association in both subgroups. Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)-positive and t(14;18)-negative FL (P<0.01). N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL. These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.

AB - Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ∼15-∼50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites. Typical FL mutations also affected t(14;18)-negative FL. Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)-negative FL. Mutated genes showed high BCL2 association in both subgroups. Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)-positive and t(14;18)-negative FL (P<0.01). N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL. These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.

UR - http://www.scopus.com/inward/record.url?scp=85037372167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037372167&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.270

DO - 10.1038/leu.2017.270

M3 - Article

AN - SCOPUS:85037372167

VL - 32

SP - 685

EP - 693

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -